Therefore, the combination of vemurafenib and mannose inhibited the levels of pERK and pAKT, thereby improving the effectiveness of PLX4032 in treating anaplastic thyroid cancer. This evidence concerns the gene EIF2AK3 and thyroid gland undifferentiated (anaplastic) carcinoma.